Abstract
Despite effective antibiotic treatment, neuronal injury is frequent among children and adults with bacterial meningitis resulting in a high rate of death and neurologic sequelae. The hematopoietic cytokine erythropoietin (EPO) provides neuroprotection in models of acute and chronic neurologic diseases. We studied whether recombinant EPO (rEPO) reduces neuronal damage in a rabbit model of Escherichia coli meningitis. Inflammation within the central nervous system (CNS) was monitored by measurement of bacterial load, pleocytosis, protein, and lactate in the cerebrospinal fluid (CSF). Neuronal damage was measured by quantification of the density of apoptotic neurons in the hippocampal dentate gyrus and the concentration of the global neuronal destruction marker neuron-specific enolase (NSE) in CSF. To increase clinical relevance, rEPO was applied as adjunctive therapy from the beginning of antibiotic therapy 12 h after infection. EPO treatment applied as an intravenous injection at a dose of 1000 IU/kg body weight resulted in plasma concentrations of 6993 ± 1406 mIU/mL, CSF concentrations of 1291 ± 568 mIU/mL, and a CSF-to-plasma ratio of 0.18 ± 0.07 (mean ± SD) 6 h after injection. Under these treatment conditions, no anti-inflammatory or neuroprotective effect of EPO was observed.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- CFU:
-
colony-forming unit
- CSF:
-
cerebrospinal fluid
- EPO:
-
erythropoietin
- rEPO:
-
recombinant human erythropoietin
- HE:
-
hematoxylin-eosin (staining)
- NSE:
-
neuron-specific enolase
References
Nau R, Brück W 2002 Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 25: 38–45
Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R 1997 Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76: 105–116
Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P 2001 Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98: 4044–4049
Digicaylioglu M, Lipton SA 2001 Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641–647
Sättler MB, Merkler D, Maier K, Stadelmann C, Ehrenreich H, Bahr M, Diem R 2004 Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ 11: S181–S192
Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, Calapai G, De Vico G, Piedimonte G, Salpietro FM, Tomasello F 2002 Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A 99: 5627–5631
Genc S, Akhisaroglu M, Kuralay F, Genc K 2002 Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci Lett 321: 73–76
Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG 2000 Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 59: 419–425
Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P 2003 Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198: 971–975
Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, Ghezzi P 2002 Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 952: 128–134
Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M 2001 Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem 276: 39469–39475
Grotta J 2002 Neuroprotection is unlikely to be effective in humans using current trial designs. Stroke 33: 306–307
Muir KW, Teal PA 2005 Why have neuro-protectants failed? Lessons learned from stroke trials. J Neurol 252: 1011–1020
Spreer A, Gerber J, Hanssen M, Schindler S, Hermann C, Lange P, Eiffert H, Nau R 2006 Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis. Pediatr Res 60: 210–215
Nau R, Zysk G, Schmidt H, Fischer FR, Stringaris AK, Stuertz K, Brück W 1997 Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis. J Antimicrob Chemother 39: 781–788
Böttcher T, Ren H, Goiny M, Gerber J, Lykkesfeldt J, Kuhnt U, Lotz M, Bunkowski S, Werner C, Schau I, Spreer A, Christen S, Nau R 2004 Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone. J Neurochem 91: 1450–1460
Nau R, Soto A, Brück W 1999 Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol 58: 265–274
Free SL, Li LM, Fish DR, Shorvon SD, Stevens JM 1996 Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis. Epilepsia 37: 400–405
Zysk G, Brück W, Gerber J, Brück Y, Prange HW, Nau R 1996 Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 55: 722–728
Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E 1999 A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19: 643–651
Demers EJ, McPherson RJ, Juul SE 2005 Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 58: 297–301
Cherian L, Goodman JC, Robertson C 2007 Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats. J Pharmacol Exp Ther 322: 789–794
Nadam J, Navarro F, Sanchez P, Moulin C, Georges B, Laglaine A, Pequignot JM, Morales A, Ryvlin P, Bezin L 2007 Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol Dis 25: 412–426
Kanaan NM, Collier TJ, Marchionini DM, McGuire SO, Fleming MF, Sortwell CE 2006 Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease. Brain Res 1068: 221–229
Xenocostas A, Cheung WK, Farrell F, Zakszewski C, Kelley M, Lutynski A, Crump M, Lipton JH, Kiss TL, Lau CY, Messner HA 2005 The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol 61: 189–195
Statler PA, McPherson RJ, Bauer LA, Kellert BA, Juul SE 2007 Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res [Epub ahead of print]
Acknowledgements
The authors thank Stefanie Bunkowski for excellent technical support.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by the Else Kröner-Fresenius-Stiftung.
Rights and permissions
About this article
Cite this article
Spreer, A., Gerber, J., Hanssen, M. et al. No Neuroprotective Effect of Erythropoietin Under Clinical Treatment Conditions in a Rabbit Model of Escherichia coli Meningitis. Pediatr Res 62, 680–683 (2007). https://doi.org/10.1203/PDR.0b013e318159af7a
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/PDR.0b013e318159af7a
This article is cited by
-
Protective effects of erythropoietin on endotoxin-related organ injury in rats
Journal of Huazhong University of Science and Technology [Medical Sciences] (2013)
